EU’s demands may impact generics
After multinational drugmakers, it's the European Union's (EU) turn to exert pressure on India to agree to provisions that could affect the registration and availability of low-cost medicines.
China to Chennai is the new route for spurious medicines
Close on the heels of Nigerian authorities unearthing Chinese-made drugs with fake ‘Made in India’ labels, the Central Drugs Standard.
Drug daddies keen to pop local deal pills
The drug lords are sniffing for deals in India.Global pharmaceutical giants, which fought bruising patent battles against Indian firms just a few years ago, have decided to bury the hatchet and forge closer ties for mutual benefit.
How Budget can help pharma sector
The Indian pharmaceutical and healthcare industry has witnessed steady growth over past years and is also expected to perform well in the future.
Watson Pharma to Buy Arrow Group For 1.75B dollars In Cash, Stock
Watson Pharmaceuticals Inc. (WPI) has agreed to acquire privately held drug maker Arrow Group in a $1.75 billion cash and stock deal, which will expand Watson's global reach and give it exclusive initial U.S. rights for the generic version of the cholesterol-lowering drug Lipitor.
Covidien leaps into new market with 130M dollars Nuvo deal
Nuvo Research is pocketing a $10 million up-front fee after forging a licensing deal with Covidien covering two topical anti-inflammatories. The developer says it will gain $15 million to $20 million more if the FDA approves Pennsaid, which is scheduled to get a regulatory decision by August 5. And another $100 million in sales milestones is on the table.
Global Pharma majors impressed with Indian Bio-Pharma IP adherence
India biopharmaceutical companies' adherence to Intellectual Property (IP) is a big attraction for international companies to enter into co-development and production alliances.
Report on pharma innovation to be released at USIBC meet
A report identifying a broad range of potential benefits of incremental pharmaceutical innovation for India would be released later this week by the US India Business Council (USIBC).
Instant remedy: Pharma co ready with swine flu vaccine
The world is now at the start of the 2009 influenza pandemic says the WHO. The good news – a pharmaceutical company says it's ready with a vaccine.
Consolidation helps foreign pharma majors lead the India rank list
Merger and acquisitions (M&As) in the domestic and international pharma industry are gradually changing the Indian pharmalandscape in favour of foreign players.
Dr Reddys Laboratories to hire 1,300 this year
Pharma major, Dr Reddy’s Laboratories Ltd will hire 1,300 employees in various categories this year.
Glaxo, Reddys team up in emerging marketsJune 15, 2009
GlaxoSmithKline has forged a partnership with Dr. Reddy's Laboratories to sell more than 100 branded drugs, some of which are still in development.
Pfizer eyes deals to raise emerging markets presence
Pfizer Inc (PFE.N), the world's largest drugmaker, is looking to conclude deals in emerging markets over coming months to raise its share of a market worth an estimated $80 billion, an executive said on Sunday.
Big Pharma gets gold star on climate change scorecard
Pharmaceutical sector striding forward on greenhouse gas emissions.
India to prepare case on drug confiscations at European ports
India is preparing its case on the repeated seizures at European ports of its consignments containing off-patent drugs meant for other developing nations before it moves the European Union and the World Trade Organisation (WTO), according to a commerce ministry official.
Pfizer eyes partnerships, acquisitions in generics
Pfizer, the world's biggest drugmaker, is seeking deals with generic pharmaceutical manufacturers to increase sales of medicines that have lost patent protection.
Indian pharma faces the big-league challenge
Large Indian companies are faced with a dilemma. Given the high expectations they have built up, the key question before them is how to grow from the present levels and keep investors hooked.
India lodges protest against Chinese drugs with fake ‘Made in India’ tag
India on Thursday said it is lodging with China a strong protest against fake anti-malarial 'Made-in-India' drugs detained by Nigerian authorities, maligning the Indian pharmaceutical industry for consignments which actually originated from the neighbouring country.
India can become a global pharma innovation hub: experts
India has the potential to emerge as a global innovation hub and the US's collabortion with Indian pharma and health companies will not only help the two countries, but also entire world, eminent experts and industry leaders said.
Drug makers eye Cambodia
Vietnamese pharmaceutical products are yet to gain a reputation in Cambodia and domestic companies have to employ specific strategies to tap the significant potential that the neighbouring nation’s market presents, several exporters say.